Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer

Tumor Biology

Volumn 30, Issue 5-6, 2009, Pages 242-248

  Liu, Xin ^a   Lam, Emily K Y ^a   Wang, Xian ^b   Zhang, Jianbin ^a   Cheng, Yuen Yee ^a   Lam, Yun W ^b   Ng, Enders K O ^a   Yu, Jun ^a   Chan, Francis K L ^a   Jin, Hongchuan ^a   Sung, Joseph J Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric cancer; Methylation; SLC19A3

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; THIAMINE; VITAMIN RECEPTOR;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; DEMETHYLATION; DISEASE MARKER; DOWN REGULATION; EARLY CANCER; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC EPIGENESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTESTINE METAPLASIA; MALE; PRECANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 73749088408     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000243767     Document Type: Article

References (22)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Ushijima T, Sasako M: Focus on gastric cancer. Cancer Cell 2004; 5: 121-125.
3. Ponder BA: Cancer genetics. Nature 2001; 411: 336-341.
4. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
5. Esteller M: Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
6. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007; 128: 683-692.
7. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002; 102: 623-628.
8. Chan MW, Chu ES, To KF, Leung WK: Quantitative detection of methylated Socs-1, a tumor suppressor gene, by a modified protocol of quantitative real time methylationspecific PCR using SYBR green and its use in early gastric cancer detection. Biotechnol Lett 2004; 26: 1289-1293.
9. Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK: Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer 2007; 97: 895-901.
10. Sato F, Meltzer SJ: CPG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006; 106: 483-493.
11. Choi IS, Wu TT: Epigenetic alterations in gastric carcinogenesis. Cell Res 2005; 15: 247-254.
12. Cheng YY, Jin H, Liu X, Siu JM, Wong YP, Ng EK, Yu J, Leung WK, Sung JJ, Chan FK: Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer 2008.
13. Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, Cullen PJ, Tao Q: Epigenetic silencing of a Ca 2+ -regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci USA 2007; 104: 12353-12358.
14. Jin H, Wang X, Ying J, Wong AH, Li H, Lee KY, Srivastava G, Chan AT, Yeo W, Ma BB, Putti TC, Lung ML, Shen ZY, Xu LY, Langford C, Tao Q: Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene 2007; 26: 7490-7498.
15. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Rocken C, Ebert MP, Chan AT, Sung JJ: Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 2008; 48: 508-518.
16. Wang LJ, Jin HC, Wang X, Lam EK, Zhang JB, Liu X, Chan FK, Si JM, Sung JJ: ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem Biophys Res Commun 2009; 379: 959-963.
17. Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D, Grossman RB, Moscow JA: Downregulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res 2003; 1: 665-673.
18. Liu S, Stromberg A, Tai HH, Moscow JA: Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol Cancer Res 2004; 2: 477-487.
19. Ganapathy V, Smith SB, Prasad PD: Slc19: The folate/thiamine transporter family. Pflügers Arch 2004; 447: 641-646.
20. Rajgopal A, Edmondnson A, Goldman ID, Zhao R: Slc19a3 encodes a second thiamine transporter THTR2. Biochim Biophys Acta 2001; 1537: 175-178.
21. Eudy JD, Spiegelstein O, Barber RC, Wlodarczyk BJ, Talbot J, Finnell RH: Identification and characterization of the human and mouse SLC19A3 gene: A novel member of the reduced folate family of micronutrient transporter genes. Mol Genet Metab 2000; 71: 581-590.
22. Lee BY, Yanamandra K, Bocchini JA Jr: Thiamin deficiency: a possible major cause of some tumors? (review). Oncol Rep 2005; 14: 1589-1592.